Παρακολούθηση
Sergio Serrano-Villar
Sergio Serrano-Villar
Hospital Universitario Ramón y Cajal, Madrid
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα salud.madrid.org
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk …
S Serrano-Villar, T Sainz, SA Lee, PW Hunt, E Sinclair, BL Shacklett, ...
PLoS pathogens 10 (5), e1004078, 2014
6952014
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ...
The lancet HIV 7 (8), e554-e564, 2020
4342020
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ...
Mucosal immunology 8 (4), 760-772, 2015
3032015
Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio
S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ...
PloS one 9 (1), e85798, 2014
2672014
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ...
Aids 30 (9), 1385-1392, 2016
2432016
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
T Sainz, S Serrano-Villar, L Díaz, MIG Tomé, MD Gurbindo, MI de José, ...
Aids 27 (9), 1513-1516, 2013
1982013
The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery
S Serrano‐Villar, S Moreno, M Fuentes‐Ferrer, C Sánchez‐Marcos, ...
HIV medicine 15 (1), 40-49, 2014
1942014
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression
S Serrano-Villar, C Gutiérrez, A Vallejo, B Hernandez-Novoa, L Díaz, ...
Journal of Infection 66 (1), 57-66, 2013
1832013
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects
S Serrano-Villar, JF Vázquez-Castellanos, A Vallejo, A Latorre, T Sainz, ...
Mucosal immunology 10 (5), 1279-1293, 2017
1372017
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection
SA Younes, ML Freeman, JC Mudd, CL Shive, A Reynaldi, S Panigrahi, ...
The Journal of clinical investigation 126 (7), 2745-2756, 2016
1222016
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients
I Iturrieta-Zuazo, CG Rita, A García-Soidán, A de Malet Pintos-Fonseca, ...
Clinical immunology 219, 108572, 2020
1162020
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
J Martínez-Sanz, A Muriel, R Ron, S Herrera, JA Pérez-Molina, S Moreno, ...
Clinical Microbiology and Infection 27 (2), 238-243, 2021
1142021
Gut bacteria metabolism impacts immune recovery in HIV-infected individuals
S Serrano-Villar, D Rojo, M Martínez-Martínez, S Deusch, ...
EBioMedicine 8, 203-216, 2016
1142016
Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers
OM Moreno‐Arrones, S Serrano‐Villar, V Perez‐Brocal, ...
Journal of the European Academy of Dermatology and Venereology 34 (2), 400-405, 2020
1062020
The impact of human immunodeficiency virus infection on gut microbiota α-diversity: an individual-level meta-analysis
SA Tuddenham, WLA Koay, N Zhao, JR White, KG Ghanem, CL Sears
Clinical Infectious Diseases 70 (4), 615-627, 2020
992020
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis
JRP Pardo, SS Villar, JCR Ramos, V Pintado
Enfermedades infecciosas y microbiologia clinica 32, 41-48, 2014
872014
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ...
Nature Communications 12 (1), 1139, 2021
832021
Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
A Goren, CG Wambier, S Herrera, J McCoy, S Vaño‐Galván, F Gioia, ...
Journal of the European Academy of Dermatology and Venereology 35 (1), e13, 2020
722020
Human immunodeficiency virus as a chronic disease: evaluation and management of nonacquired immune deficiency syndrome-defining conditions
S Serrano-Villar, F Gutiérrez, C Miralles, J Berenguer, A Rivero, ...
Open Forum Infectious Diseases 3 (2), ofw097, 2016
712016
Smoking cessation in HIV patients: rate of success and associated factors
M Fuster, V Estrada, MC Fernandez‐Pinilla, ME Fuentes‐Ferrer, ...
HIV medicine 10 (10), 614-619, 2009
702009
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20